LEVERAGE EXPERTISE FROM AN EXPERIENCED PHARMA AI STRATEGY TEAM
Leverage our expertise and years of impact to utilise AI/FutureTech strategically to uncover efficiency and deliver growth sustainable
Today we have a greater emphasis on patient outcomes, expanded access, and greater affordability, combined with advances in artificial intelligence (AI) and big data and shifting customer expectations, have seeded a perfect storm in the world of pharmaceuticals. Navigating it will require a radical and far-reaching change from the pharmaceutical industry—something it’s been historically slow to accomplish.
Past problems related to declining R&D productivity, shrinking pipelines, and pushback from payers have been staved off through aggressive M&A schemes, soaring prices, moderately performative line extensions, patents (expiring today in ever greater numbers as we head to the next patent cliff), and pharma’s “too-big-to-fail” Blockbuster business model. But these tactics are no longer working. Yesterday’s solutions can no longer sustain us to thrive in the coming decade.
Artificial intelligence (AI) can be used to solve a wide range of problems in the healthcare industry, for patients and practitioners as well as for biopharma companies.
There is no shortage of opportunities for the application of AI solutions. And yet, pharma consistently struggles to meet these opportunities when using such tools. An astonishing number of AI projects never make it off the ground or past the pilot stage, encounter disappointing and costly setbacks, or else fail to produce the kinds of results businesses hope for and expect.
Part of the problem we see when biopharma companies begin their digital transformation journey is that they begin with technology and start looking at different tech options. But it should not start with tech, or even be about tech (tech is an enabler). It is about making the customer experience and customer journey better while making the company processes more efficient and bringing in more revenue due to enhanced customer experience, enhanced business processes and unearthing new growth opportunities through data. So, it is about change and making the process better for both customers and the company.
At Eularis, for example, we’ve successfully leveraged AI and machine learning (ML) to improve business processes across the value chain. Go here to see some examples of our case studies.
Like so many things in business (and life), these difficulties often stem from a fundamental lack of planning and preparation. Artificial intelligence comprises a powerful set of tools, but understanding which of these to use strategically, and how best to implement them is key to its successful deployment. From our 20 years in biopharma AI we have learned that to succeed with AI, you must begin with a strategic AI Blueprint, to ensure your solutions are strategically aligned with your corporate needs and objectives. Only this way can success be assured.
Do you recognize yourself here?
- Your department needs to make cuts but you are all already working at maximum capacity
- Getting access to HCPs and other stakeholders is getting more and more difficult
- You need to find pockets of growth to mitigate LOE while new pipeline products get to market
- You need to accelerate the speed of getting new products to market effectively
- Your marketing is difficult to measure results and difficult to integrate with other channels
- Your board and C suite want want a digital transformation but need help
- You need to deliver short terms results while reshaping the organization for the longer term
- Your company has implemented AI but has not got the returns hoped for
- Difficulty accessing patient data and having the personalization needed
- There are internal gaps in being able to scale AI projects effectively
Who are we?
As big pharma considers new efficiency and growth scenarios, together with ensuring their digital transformation will achieve reliable returns now and into the future, we are here to help guide you to success.
Led by Dr Andree Bates, we combine an extensive global network of experts to accelerate strategic innovation and commercialisation of turning complex pharmaceutical challenges into sustainable growth opportunities using AI and FutureTech.
The Eularis team of experts have extensive qualifications combined with many years of real-world experience. The mix of qualifications (MD, PhD, MBA, M. Sc., M Engin.) along with decades of experience in executive-level positions in top 20 pharmaceutical companies, and AI companies, ensures our clients have the right strategic and tactical questions solved and planned with cutting edge technology and AI.
Our global reach and experience within the global Pharmaceutical sector and AI tech sector, gives us a unique lens on the problem-solution fit while assessing adjacent sectors to accelerate the evaluation of the most sustainable opinions for your success.
A talented team trusted by global pharma
A selection of the companies we have worked with.
What is our focus?
BioPharma and Healthcare Focus
Eularis works with biopharma and healthcare companies and we have a strong understanding of clinical and commercial strategy and regulatory and compliance requirements.
All Work Powered by Artificial Intelligence (AI)
There is no one-size-fits-all. Each project is unique which means you need to be looking at your specific challenges and find the right solution to suit your needs. We focus on AI solutions although we are doing more and more AR/VR/IOT work as part of this.
Proven Results
With over 20 years in the biopharma AI space, Eularis has proven results and worked on most biopharma and healthcare challenges in all major markets – and many minor markets also.
in pharma & healthcare AI and FutureTech
cups of coffee consumed each week by Eularis team
Net Promoter Score
projects delivered within budget
Eularis Insights Featured in These and More
Guiding you to accelerate sustainable efficiencies and growth in the 'New Normal'
We exist to guide pharmaceutical leaders and innovators to enhance efficiencies and accelerate growth and profitable returns in a post-pandemic world.
We help our pharmaceutical clients to adapt rapidly to the changing environment by continuously solving complex pharmaceutical commercial challenges.
We combine and apply our deep expertise in pharmaceuticals and AI/FutureTech, with strategic-led planning within our proven frameworks to develop sustainable strategic growth initiatives while adapting to changing customer needs, approaches, and business models.
"AI allows you to supercharge your efficiency and results but it does have to be strategically-led. And it doesn't have to be difficult for you either. But, you do have to start with strategy and not tech."
If you want expert advice to take you from data to measurable results, contact us today.
Want more?
We got you covered!